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ABSTRACT 
Notch1 is a transmembrane protein involved in cell signaling, which is found to be linked 
to various genetic and neurodegenerative diseases.1-2 The extracellular domain of the Notch1 
protein consists of 36 tandem epidermal growth factor-like (EGF) repeats, which are directly 
involved in ligand binding and are heavily glycosylated.1 EGF 24-29 repeats lie in the Abruptex 
region of the Notch1 protein, and regulate the ligand binding activity through structural changes.1 
The role of glycosylation in ligand binding events and the overall structure of the Abruptex region 
are not known. Also, the role of calcium binding in Notch activation or inhibition is not clear. The 
goal of this project is to use NMR spectroscopy to study the structure of EGF domains with and 
without glycosylation, and a three dimensional structure of the Abruptex EGF repeats will be 
determined. The structures will provide a model to the Abruptex region of Notch1 and will further 
aid in our understanding of ligand binding activity in the extracellular domain of the Notch1. 
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
1.1 Proteins and Protein Structure 
Proteins are large biomolecules or macromolecules that play an important role in all living 
things. They are responsible for chemical processes occurring in living organisms, and play a 
large role in tissue and organ system regulation and function.3-4 Formation of proteins begins with 
the transcription process, which transfers genetic information from deoxyribonucleic acid (DNA) 
to messenger-ribonucleic acid (mRNA). Translation of mRNA produces proteins as shown in 
Figure 1. Ribosomes and translational RNA (tRNA, a non-protein coding gene) bind to the mRNA 
(protein coding gene) in the cytoplasm of the cell to form an amino acid chain linked by the peptide 
bond, which then folds to form proteins.4 
 
 
Figure 1. Schematic of protein synthesis in a living cell. DNA transcribes information to mRNA, 
which is then translated to form proteins. During the transcription process, a double-helix anti-
parallel strand of DNA carries genetic information. DNA transcription makes an RNA copy of a 
gene sequence to form mRNA in the nucleus of a cell. The mRNA is a single-stranded RNA 
molecule, which is complementary to one of the DNA strands. The mRNA is then transported 
from the nucleus to the cytoplasm of the cell where proteins are formed by translation. During 
translation, the ribosome reads the mRNA triplet base codon and translates it into a specific amino 
acid. During this process, a tRNA molecule confirms the newly formed amino acid in a protein 
sequence by attaching its three complementary bases with an mRNA codon forming a base pair. 
http://www.genome.gov/glossary/ 
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Proteins are made of a polypeptide chain comprising 20 different naturally occurring amino 
acids, which are the building blocks. An amino acid backbone is made of a central carbon atom 
(Cα) attached to an amino group (–NH2), a carboxyl group (–COOH), and a side chain (–R) that 
varies from one amino acid to another as shown in Figure 2 (a). Two amino acid residues are 
joined together by a peptide bond formed by the dehydration reaction that occurs between the 
amino group of one amino acid residue and the carboxyl group of another amino acid residue to 
form a polypeptide chain as shown in Figure 2 (b). Each of the 20 different amino acids has a 
specific side-chain that governs the chemistries of the polypeptide chain to give a shape or 
conformation to the protein molecule. The different types of side chain that exist in a protein 
molecule are electrically charged (either positively or negatively charged), polar uncharged, and 
hydrophobic side chains that usually form non-covalent bonds. Some amino acid side chains have 
special properties, such as: (1) cysteine, which can form covalent disulfide bonds between two 
cysteine residues, (2) proline, which has a cyclic bond with the amino group in the backbone, and 
(3) glycine that is the simplest and one of the most stable naturally occurring amino acids.4-5 
Proteins are further classified into different levels according to their structure.  
A linear polypeptide chain of amino acids gives the primary structure of a protein. 
Hydrogen bonding between the amino acid residues in a protein sequence forms alpha helices 
and beta (pleated) sheets giving the protein its secondary structure. A tertiary structure is formed 
Figure 2. (a) Amino acid backbone consisting of an amino group and a carboxyl group with a 
variable side chain. (b) Amino acid residues linked together by a peptide bond forming a 
polypeptide chain.2  
(a) (b) 
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when the alpha helices and beta sheets arrange in a pattern or a fold to give a certain 
conformation. The structure containing multiple polypeptide chains arranges to form the 
quaternary structure of a protein.4-5 Figure 3 gives a representation of each of these levels of 
protein structure. Besides these different structures, proteins undergo several modifications once 
they are formed. 
1.2 Post-translational Modifications 
After translation, proteins further undergo post-translational modification (PTM). PTMs 
affect several cellular processes in living organisms such as cell cycle, differentiation, 
proliferation, and apoptosis.6 PTMs occur either by the covalent addition of a functional group to 
a protein or a proteolytic cleavage. More than 200 PTMs have been identified. Some of the most 
Figure 3. Levels of protein structure showing primary structure, secondary structure, tertiary 
structure, and quaternary structure. The primary structure is made of a linear polypeptide chain 
of amino acids. The secondary structure forms when the amino acids are linked together to form 
alpha helices and beta (pleated) sheets. These secondary structures then attract together to form 
a tertiary structure. Multiple amino acid chains then form the quaternary structure. 
http://www.genome.gov/glossary/ 
Primary 
structure 
Secondary 
structure 
Tertiary 
structure 
Quaternary 
structure 
4 
 
common PTMs that occur are methylation, acetylation, phosphorylation, and glycosylation.7 
Protein phosphorylation is a well-studied modification commonly occurring on serine, threonine 
and tyrosine when a phosphate group is added to these residues. Protein glycosylation is one of 
the most common modifications, in which glycans or sugar residues are attached to the functional 
group of a protein molecule. Protein glycosylation generally occurs as O-linked glycosylation and 
N-linked glycosylation. In O-linked glycosylation, glycans are covalently bound via the oxygen 
atom in the hydroxyl group of serine and threonine residues. In N-linked glycosylation, glycans 
are covalently bound to nitrogen of asparagine and arginine residues.8-9 Protein glycosylation 
affects protein folding and stability.7, 10 Protein methylation is the addition of a methyl group to an 
arginine or lysine amino acid residue.11 Acetylation is the modification that occurs when an acetyl 
group is added to the N-terminal amino group.12 One such protein that undergoes various PTMs 
is Notch1. 
1.3 Notch1 Protein 
Notch1 is a transmembrane receptor protein involved in cell signaling, which is vital for 
cell development and activity.1 Dysregulation in Notch1 signaling has been found to be associated 
with various developmental disorders in humans including neurodegenerative diseases and 
cancer.1-2 For this reason, the Notch1 signaling pathway plays an important role in human 
genetics regulating cell fate by maintaining a balance between cell differentiation, proliferation, 
and apoptosis.13 The Notch1 receptor consists of an extracellular domain (ECD) and an 
intracellular domain (ICD) as shown in Figure 4. The ECD of Notch1 is comprised of tandem 
epidermal growth factor-like (EGF) repeats. The human Notch1 receptor has two ligands: Delta-
like-1 and Jagged-1. Notch1 ligands incorporate a receptor-binding Delta-like-1 or Jagged-1 
domain with a variable number of (6-8) tandem EGF-like repeats, and are expressed on the cell 
surface.13-15 A cell signal is transmitted when the ECD binds ligands from the signal-sending cells 
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and passes an intercellular signal to the signal-receiving cells via proteolytic cleavage of the ICD 
as shown in Figure 4 (b).  
1.4 Notch1 Extracellular Domain and EGF-like Repeats 
The Notch1 extracellular domain (ECD) is an important segment of the Notch1 receptor, 
which is responsible for transmitting signals between cells. The Notch1 ECD is made of 36 tandem 
EGF-like repeats and a negative regulatory region (Figure 4). An EGF-like repeat is a small protein 
with 40 amino acid residues that consist of six-conserved cysteine (Cys) residues, which forms 
three disulfide bonds bridged by Cys1–Cys3, Cys2–Cys4, and Cys5–Cys6 as shown in Figure 5.1, 16 
Each EGF-like repeat is represented by an oval, as shown in Figure 4, and numbered from 1 to 
36 (top to bottom). Once the ligand binds, each of these EGF-like repeats then help to transmit 
the cell signal downstream. EGF 11-12 of the Notch1 ECD is the site where Delta-like-1 and 
Figure 4. (a) Schematic of the mouse Notch1 extracellular domain (ECD) receptor. The ECD has 
36 epidermal growth factor-like (EGF) repeats represented by ovals. EGF 11-12 is the ligand 
binding domain, and EGF 24-29 is the Abruptex region. The red, blue, or red-blue lined ovals 
represent the consensus sequence for O-fucosylation, O-glucosylation, or both, respectively. (b) 
Schematic of the Notch signaling pathway. The signal sending cell transmits genetic information 
via DSL (Delta, Serrate, Lag-2) ligand interaction with the Notch ECD. The signal further passes 
down to the NRR and ICD in the signal receiving cell. Reproduced from (Rana, N. A.; Haltiwanger, 
R. S., Fringe benefits: Functional and structural impacts of O-glycosylation on the extracellular 
domain of Notch receptors. Current Opinion in Structural Biology 2011, 21 (5), 583-589.) with 
permission from the publisher. 
(b) 
Extracellular 
domain (ECD) 
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Jagged-1 ligands interact and is called the ligand binding domain. EGF 24-29 is a flexible region 
called the Abruptex region that regulates ligand binding specificity.1, 17 
1.4.1 Ligand Binding 
Another important domain for cell signaling within the Notch 1 ECD is the Ligand Binding 
Domain that recognizes the ligand and transmits the signal downstream ultimately to the ICD.  
Ligand binding is regulated by interactions between the Abruptex region and the Ligand Binding 
Domain of the Notch ECD.18 Delta/Serrate/Lag-2 (DSL) domains are the disulfide-rich ligands that 
are involved in Notch activation by trans-ligand binding or inhibition by cis-ligand binding events.19-
20 Drosophila have only one Notch receptor with two ligands, Delta and Serrate, whereas 
mammalian cells have four Notch receptors and five ligands, Delta-like-1, Delta-like-3, Delta-like-
4, Jagged-1, and Jagged-2.15 EGF25-29 repeats lie in the Abruptex region of the Notch1 protein 
and are believed to regulate ligand binding through structural changes.1 The activation or 
inhibition of Notch signaling is also regulated by calcium binding and glycosylation of the EGF 
Figure 5. Schematic of Notch1 epidermal growth factor (EGF)-like repeat forming three disulfide 
bonds between six conserved cysteine residues in a 1-3, 2-4, 5-6 pattern. Each circle represents 
an amino acid residue: Yellow circles numbered 1-6 are the six conserved cysteine residues. The 
circle with the letter ‘X’ may be any amino acid residue and the letter ‘a’ is an aromatic residue. 
The blue circle with a letter S is a serine residue and is a site for O-glucosylation. The red circle 
with a letter S/T is a serine or threonine residue and is a site for O-fucosylation. The circle with a 
letter P/A is a proline or alanine residue, and the circle with a letter G is a glycine residue. An O-
GlcNAc modification can occur between cysteine 5-6 at the serine or threonine residue. A sugar 
is added to an amino acid residue or glycan by a specific glycosyltransferase enzyme represented 
by an arrow. Reproduced from (Rana, N. A.; Haltiwanger, R. S., Fringe benefits: Functional and 
structural impacts of O-glycosylation on the extracellular domain of Notch receptors. Current 
Opinion in Structural Biology 2011, 21 (5), 583-589.) with permission from the publisher. 
     O-fucose 
     Glucose 
     Xylose 
     GlcNAc 
     Galactose 
     Sialic acid 
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repeats.15, 19, 21 Several studies have explained the Notch1 activation, which starts with ligand 
binding to the Notch1 ECD that eventually triggers the proteolytic cleavage of the Notch ICD.22 
Therefore, Notch1 activation is dependent on the binding of the ligands with the Notch1 ECD. 
1.4.2 Role of Calcium Binding 
Many EGF-like repeats of the Notch1 ECD are capable of binding calcium ions, which help 
to maintain heterodimeric stability between the ligand and the Notch1 ECD during the cell 
signaling process.23 A heterodimer consist of two different polypeptide chains that are linked by 
non-covalent interactions. This heterodimer formation helps to stabilize the large ECD with the 
membrane bound ICD.24 Calcium regulates Notch protein-protein interactions as well as its 
activation or inhibition by interacting with the DSL ligands.15, 23 The Ligand Binding Domain (EGF 
11-12) of Notch1 has a conserved calcium binding site between the domains. Calcium binding 
provides rigidity and helps to align the tandem EGF-like repeats in a rod-like shape.25-26 EGF 24-
29 is the Abruptex region, which is a highly glycosylated and flexible region of the Notch1 ECD 
as it lacks calcium binding sites between EGF 27-29.1, 17 Furthermore, attachment of calcium 
between the tandem EGF domains helps to stabilize the Notch structure.27 
1.4.3 Roles of Glycosylation 
Glycosylation occurs when a sugar molecule attaches to the EGF domain of the Notch1 
protein and subsequently regulates cell signaling. A properly folded EGF repeat can be modified 
by two types of O-glycosylation: O-fucosylation and O-glucosylation.16 O-fucosylation involves the 
protein O-fucosyltransferase (Pofut1) enzyme that catalyzes the transfer of O-linked fucose from 
guanosine 5'-diphosphate (GDP) -fucose to EGF-like repeats. O-glucosylation involves the 
protein O-glucosyltransferase enzyme, Rumi/Poglut1, which catalyzes the transfer of O-linked 
glucose from uridine diphosphate (UDP) -glucose to EGF-like repeats.16 Several studies in the 
past decade, primarily focusing on O-fucosylation of EGF repeats, have revealed its effect on 
Notch signaling activity.1, 20, 28 Pofut1 is necessary for the proper folding and ligand interaction of 
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Notch.29 A glycosyltransferase enzyme, Fringe, elongates the O-fucose residue by adding N-
acetylglucosamine (GlcNAc), which directly affects the Notch-ligand interactions.29-30 A study in 
Drosophila has shown that the addition of O-fucose to Notch EGF12 suppressed the Notch 
signaling activity; however, several other studies have shown that O-fucosylation helps in ligand 
mediated Notch activation.28, 31 In addition, a recent study in Drosophila shows that O-glucose 
alters Notch ECD conformation and regulates the activation of Notch.29 
1.5 EGF-like Repeat Structures, Calcium Binding, and Glycosylation 
EGF-like repeat structures form the Notch1 ECD, which regulates cell signaling. An EGF-
like repeat of mouse Notch1 consist of amino acid residues that are directly involved in ligand 
binding and are heavily glycosylated.1 The six cysteine residues in an EGF domain arrange in a 
1–3, 2–4, 5–6 pattern to form three disulfide bonds, which predominantly define its tertiary 
structure.23, 25 Calcium binding and glycosylation, which regulate Notch signaling, occur at EGF 
domains in a conserved manner. 
The EGF-like repeats form rod and U-shaped structures in the presence or absence of 
calcium, respectively.19, 26, 32-34 The tandem EGF repeats are aligned and are made rigid by 
calcium binding, and are more flexible in the absence of binding as shown in Figure 6 (a) and 
(b).25-26 Calcium binding occurs at the linker region of the two tandem EGF repeats that follow a 
Figure 6. (a) The structure of human Notch1 EGF11-13 (PDB: 2VJ3)17 showing coils (orange) 
and strands (purple). Green spheres represent calcium residues bound at the linker region 
between two tandem EGF-like repeats. Calcium binding gives a distinct rod-shaped structure. (b) 
The structure of Plasmodium falciparum merozoite surface protein 1 (PDB: 1CEJ)29 showing coils 
(green) and strands (blue). This protein lacks calcium and is more flexible giving a “U-shaped” 
structure. The structures were obtained from the Research Collaboratory for Structural 
Bioinformatics (RCSB) Protein Data Bank (PDB). 
(a) (b) 
EGF11 EGF12 EGF13 
EGF1 
EGF2 
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consensus sequence for calcium binding. The consensus calcium binding site for the Notch EGF-
like repeat follows the sequence (D/N/E)X(D/N/E)(E/D/Q)C1. . .C3X(D/N)XXXX(Y/F)XC4, where “/” 
represents “or”, X can be any amino acid residue, and C1 to C4 are the first through fourth 
conserved cysteine residues.17 
Glycosylation helps to regulate cell signaling by providing the modifications needed for the 
ligand-binding domain on the properly folded Notch 1 protein to recognize the ligand. Protein 
folding occurs in the endoplasmic reticulum (ER) of the cell during protein synthesis.35 A properly 
folded protein in its native state has its disulfide bonds correctly formed in the ER during protein 
biosynthesis.16 An EGF repeat in its native state can be modified by O-glucosylation and O-
fucosylation in the presence of glycosyltransferase enzymes. Several studies done on Notch 
glycosylation have developed a consensus sequence for the addition of O-glucose and O-fucose 
on the EGF domains. The consensus O-glucose site on Notch EGF domain is C1X(S)X(P/A)C2 
and O-fucose site is C2XXXX(S/T)C3, where “/” represents “or”, X can be any amino acid, and C1 
to C3 are the first through third conserved cysteine residues.16-17 
1.6 Unknowns 
While calcium binding and glycosylation both affect the Notch signaling activity, the 
molecular mechanism by which Notch is activated or inhibited is still not clear. Also, the effect of 
glycosylation on inter-domain structure is not known. Since Notch regulation is directly associated 
with cell signaling for cell growth and development, it is important to understand the molecular 
mechanism governing the process. Furthermore, Notch ligands are promising therapeutic targets 
due to their importance in neuroscience, cancer, angiogenesis, and stem cell biology is 
prominent.36 
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CHAPTER 2. EXPRESSION AND CHARACTERIZATION OF MOUSE 
NOTCH1 ABRUPTEX EGF-LIKE REPEATS IN E. COLI 
2.1 Introduction 
2.1.1 Notch1 Abruptex EGF-like Repeats 
Notch1 is a transmembrane receptor protein involved in cell signaling. Signal transduction 
between adjacent cells occur via Notch extracellular domain (ECD) after binding with Delta-like-
1 or Jagged-1 ligands. The ECD of Notch1 consists of 36 tandem EGF-like repeats, where 
glycosylation and calcium binding occurs. The Abruptex region of the Notch1 ECD is one of the 
sites for glycosylation, which plays an important role in Notch regulation. Notch1 EGF repeats 
also have consensus sites for calcium binding. Calcium coordination occurs at the linker region 
between two adjacent repeats and provides rigidity to the inter-repeat structures. The rigid rod-
shaped inter-repeat structures preclude flexibility, which is important for protein stability and 
functioning. Some studies in the past have suggested that the Abruptex region of Notch1 
competes with the Ligand binding domain for the receptor activation.37 However, the molecular 
mechanism by which the Abruptex region affects Notch regulation is not fully understood. 
2.1.2 Research Goal 
The immediate goal of this research is to express and purify properly folded Abruptex EGF 
repeats in milligram quantities for NMR studies. The long term goals of this project are to 
determine the three dimensional structures of the EGF repeats in the Abruptex region of mouse 
Notch1 with and without glycosylation to understand the role of the glycans in EGF structure. The 
results will help to further understand how Notch1 signaling is regulated and will aid in the 
discovery of new drug targets in the future. 
2.2 Materials and Methods 
The preliminary step to attain the long-term goals of this project is described in this thesis, 
which is to express, purify, and characterize properly folded EGF repeats in milligram quantities. 
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2.2.1 Materials 
The pET-20b-pelB-EGF27 plasmid was obtained from Dr. Robert Haltiwanger (Stony 
Brooke University, NY). pET-28a plasmid, Novagen Bugbuster 10X protein extraction reagent, 
and MF – membrane filters 0.025μm VSWP were purchased from EMD Millipore. NcoI, XhoI, and 
NdeI restriction enzymes, T4 DNA ligase, Taq 5x Master Mix, 2-Log DNA Ladder, NEB 10-beta 
electrocompetent E. coli cells, NEB 5-alpha competent E. coli cells, SOC outgrowth medium, and 
Shuffle T7 Express competent E. coli cells were purchased from New England BioLabs Inc. 
Sodium chloride (NaCl), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), urea, 
imidazole, tris(hydroxymethyl)aminomethane (Tris), sodium azide, 2-(N-
morpholino)ethanesulfonic acid hydrate (MES), calcium chloride, tricine, acetonitrile, 
trifluoroacetic acid (TFA), potassium phosphate monobasic (KH2PO4), magnesium sulfate 
(MgSO4), D-glucose monohydrate, ammonium chloride, thiamin hydrochloride, biotin, choline 
chloride, folic acid, nicotinamide, D-pantothenic acid hemicalcium salt, pyridoxal hydrochloride, 
riboflavin, tetracycline hydrochloride, sodium dodecyl sulfate (SDS), 2-mercaptoethanol (βME), 
acetic acid, Coomassie brilliant blue R 250, and 3-(trimethylsilyl)-1-propanesulfonic acid sodium 
salt (DSS) were purchased from Sigma-Aldrich/Fluka. Profinity immobilized metal affinity 
chromatography (IMAC) resin, Bio-Gel P-4 gel, an ENrich SEC 70 10x300 mm column, Precision 
Plus Protein Dual Xtra Standard, 4–20% Tris-HCl Mini-PROTEAN TGX precast gels, 10–20% 
Mini-PROTEAN Tris-Tricine precast gels, 2x Laemmli sample buffer, and tricine sample buffer 
were purchased from Bio-Rad. Agarose, sodium phosphate dibasic heptahydrate 
(Na2HPO4.7H2O), Pierce Protease inhibitor tablets – EDTA free, EZ-Run Rec Protein Ladder, 
Coomassie Plus (Bradford) protein assay reagent, and bovine serum albumin (BSA) standard 
were purchased from Fisher/Thermo Scientific. Difco Luria-Bertani (LB) broth – Miller (developed 
by Miller) and LB Agar – Lennox (developed by Lennox) were purchased from BD Biosciences. 
Shigemi NMR tubes, BDH methanol, and centrifuge tubes were purchased from VWR 
International. 15N labeled – ammonium chloride and deuterated water (D2O) were purchased from 
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Cambridge Isotope Laboratories. Other chemicals used were isopropyl β-D-1-
thiogalactopyranoside (IPTG) from Anatrace, phenylmethylsulfonyl fluoride (PMSF) from 
Calbiochem, QIAprep spin miniprep kit from Qiagen, Costar 96 well UV transparent flat bottom 
plates from Corning, kanamycin sulfate from Genlantis, glycine from Amresco, BL21-Gold(DE3) 
competent cells from Agilent Technologies, and primers from Integrated DNA Technologies (IDT). 
A Millipore Direct-Q 3 ultrapure water system was used as a source for all experiments. 
2.2.2 Cloning 
A pSec Tag plasmid containing the mouse Notch1 (mN1) EGF1-36 nucleotide sequence 
was obtained from Dr. Robert Haltiwanger at Stony Brook University, NY. The mN1 EGF1-36 
protein has 1408 amino acid residues. To produce small protein constructs of the Abruptex region 
(EGF24-29), nucleotide sequences were cloned from the pSec Tag plasmid into other expression 
plasmids. The sequences for all plasmids made and used in this study are included in the 
Appendix section. The amino acid residues for each plasmid are numbered based on the mN1 
EGF1-36 sequence. The EGF26-27-28 sequence (residues E961-S1078 based on mN1 EGF1-
36 amino acid sequence) was cloned into the pET-28b expression plasmid with a C-terminal 
6XHis tag (pET-28b-EGF26-27-28-6XHis). The EGF25-26-27 sequence (residues E923-V1040 
based on mN1 EGF1-36 amino acid sequence) was cloned into the pET-28b expression plasmid 
with a C-terminal 6XHis tag (pET-28b-EGF25-26-27-6XHis). The EGF25 sequence has an extra 
cysteine residue, so the residue count at the 21st position in EGF25-26 sequence (or residue 
number 943 in the mN1 EGF1-36 sequence) is a cysteine, which was mutated to glycine. The 
EGF25-26-C21G sequence (residues E924-Q999) was cloned into the pET-28a expression 
plasmid with a C-terminal 6XHis tag (pET-28a-EGF-25-26-C21G-6XHis). The EGF25-26-C21G 
sequence (residues E924-Q999) was cloned with a TEV cleavage site into the pLIC-EGFP 
expression plasmid with a C-terminal 6XHis tag (pLIC-EGF25-26-C21G-TEV-EGFP-6XHis). The 
EGF27 (residues D1001-W1042) with a pelB leader sequence (pelB-EGF27) was cloned with a 
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TEV cleavage site into the pLIC-EGFP expression plasmid with a C-terminal 6XHis tag (pLIC-
pelB-EGF27-TEV-EGFP-6XHis). The EGF27 (residues D1001-W1042) without pelB was cloned 
with a TEV cleavage site into the pLIC-EGFP expression plasmid with a C-terminal 6XHis tag 
(pLIC-EGF27-TEV-EGFP-6XHis). All of the cloning work mentioned above was performed by the 
LSU AgCenter Biotechnology Laboratory (ABL) Protein Facility. 
Table 1. EGF constructs with their residue count based on EGF1-36 amino acid sequence. 
Plasmid Residue count 
EGF1-36 G1-L1408 
EGF26-27-28 E961-S1078 
EGF25-26-27 E923-V1040 
EGF25-26-C21G E924-Q999 
EGF27 D1001-W1042 
 
A sub-cloning experiment was performed to remove EGF27 (residues D1001-W1042) 
without the pelB leader sequence from pET-20b-pelB-EGF27-6XHis. The EGF27 insert was sub-
cloned into the pET-28a expression plasmid to construct the pET-28a-EGF27-6XHis plasmid. The 
pET20b-pelB-EGF27-6XHis containing the insert with a C-terminal 6XHis tag and the pET-28a 
expression plasmid were double digested separately using the restriction enzymes NcoI and XhoI. 
A 50 µL double digestion reaction was prepared by mixing 2 μL (1 μg) of plasmid (vector or insert), 
5 μL (1X) of 10X NEBuffer 3.1, 41 μL of autoclaved Millipore water, and 1 μL (10 units) each of 
restriction enzymes NcoI and XhoI. Restriction enzymes were the last thing added in the mixture 
(Table 2). 
The two 50 μL double digestion reactions (vector and insert) were incubated at 37°C for 
one hour. The restriction enzymes were heat-inactivated immediately by incubating the reaction 
mixture at 80°C for 20 minutes. The EGF27 insert was ligated into the digested pET-28a vector 
by mixing 2 μL (1X) of 10X T4 DNA ligase buffer, 2 μL each of the double digested vector and 
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insert, 13 μL of autoclaved Millipore water, and 1 μL of T4 DNA ligase enzyme. T4 DNA ligase 
enzyme was the last thing added in the mixture (Table 3). 
Table 2. Protocol for double digestion reaction (50 μL reaction). 
 
Table 3. Protocol for ligation reaction (20 μL reaction). 
   
The ligation reaction was incubated at 16°C for two hours. The ligase enzyme was heat-
inactivated immediately by incubating the reaction mixture at 65°C for 10 minutes and chilled on 
ice immediately. A post-ligation cut was performed by using the restriction enzyme NdeI to remove 
incorrectly cloned plasmid. 2 µL of 10X NEBuffer 3.1 and 1 µL (10 units) of NdeI restriction 
enzyme were added to the completed ligation reaction from above and incubated at 37°C for one 
hour. The restriction enzyme was heat-inactivated immediately by incubating the reaction mixture 
at 65°C for 20 minutes and immediately chilled on ice. The pET28a-EGF27 plasmid was desalted 
into autoclaved Millipore water using a 0.025 μm VSWP membrane filter.  
The sub-cloned pET28a-EGF27 plasmid (2.5 µL) was transformed into NEB 5-alpha 
competent E. coli cloning strain cells following NEB heat shock transformation protocol. 2.5 µL of 
plasmid was mixed with 50 µL of competent cells and was incubated on ice for 2 minutes. Without 
Plasmid (vector or insert) 2 μL (1 μg) 
10X NEBuffer 3.1 5 μL 
Autoclaved Millipore water 41 μL 
Restriction Enzyme – NcoI 1 μL (10 units) 
Restriction Enzyme – XhoI 1 μL (10 units) 
10X T4 DNA Ligase Buffer 2 μL 
Vector plasmid (double-digested) 2 μL 
Insert plasmid (double-digested) 2 μL 
Autoclaved Millipore water 13 μL 
T4 DNA Ligase 1 μL 
15 
 
mixing or disturbing, the mixture was heat shocked at exactly 42°C for 30 seconds, and was 
immediately placed on ice for another 2 minutes. 950 µL of room temperature SOC medium was 
added into the mixture, and the mixture was incubated at 37°C with 250 rpm shaking for 1 hour. 
The transformation mixture was plated on LB agar containing 50 µg/mL kanamycin and incubated 
overnight (16 hours) at 37°C. 
Table 4. Reaction setup protocol for the polymerase chain reaction (PCR) (25 µL reaction). 
10 µM Forward Primer 0.5 µL 
10 µM Reverse Primer 0.5 µL 
Autoclaved Millipore water 19 µL 
Taq 5X Master Mix 5 µL 
 
The presence of pET28a-EGF27 in the colonies was verified by polymerase chain reaction 
(PCR). Colony PCR was performed by selecting individual colonies from the freshly grown 
transformation plate. The forward primer used was IDT Readymade 51-01-16-07 (pET 3’) 5’-
CTAGTTATTGCTCAGCGG-3’ and the reverse primer was IDT Readymade 51-01-16-08 (pET 5’ 
or T7) 5’-TAATACGACTCACTATAGG-3’. The PCR reaction mixture consisting of 0.5 µL of 10 
µM each of the forward and reverse primers, 19 µL of autoclaved Millipore water, and 5 µL of Taq 
5X Master Mix was added together and chilled on ice. Taq 5X Master Mix was the last thing added 
in the mixture (Table 4). A small amount of a single bacterial colony from the transformation plate 
was picked with a sterile toothpick and dissolved in the PCR reaction mixture. The reaction 
mixture was transferred to a PCR cycler (Bio-Rad S1000 thermal cycler), and the PCR was 
performed. The cycling conditions include an initial 1 cycle denaturation at 95°C for 45 seconds, 
30 cycles consisting of denaturation at 95°C for 45 seconds, annealing at 40°C for 30 seconds, 
extension at 72°C for 90 seconds, 1 cycle final extension at 72°C for 5 minutes, and 4°C hold until 
the instrument is turned off (Table 5). 
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The PCR reaction product was mixed with the DNA loading dye and the mixture was 
directly loaded onto a 1% agarose gel containing 0.2 µg/mL ethidium bromide for the DNA 
agarose gel electrophoresis analysis. After confirmation of the pET28a-EGF27 from the gel, a 10 
mL starter culture of the selected colony was grown in LB broth media containing 50 μg/mL 
kanamycin. The starter culture was grown overnight at 37°C on an orbital shaker at 250 rpm. The 
plasmid was purified from the starter culture using the QIAGEN miniprep plasmid purification kit 
and was sequenced by the GeneLab in the LSU School of Veterinary Medicine. A 1 mL freezer 
stock in 15% glycerol was prepared by mixing 500 µL of the overnight starter culture of colony 
with the correct plasmid sequence with 500 µL of 30% sterile (autoclaved) glycerol stock and 
stored at -80°C immediately. 
Table 5. PCR cycling conditions protocol. 
Step Temperature Time 
Initial Denaturation 95°C 45 seconds 
30 Cycles 
95°C 45 seconds 
40°C 30 seconds 
72°C 90 seconds 
Final Extension 72°C 5 minutes 
Hold 4°C  
 
2.2.3 Recombinant Protein Expression in E. coli 
The EGF protein constructs were expressed by transforming the appropriate plasmid into 
BL21-Gold (DE3), Shuffle T7 Express, or Shuffle T7 Express lysY competent E. coli cells using a 
heat shock transformation protocol. Transformed colonies were grown on LB agar plates 
supplemented with the appropriate antibiotics. Unless otherwise stated, the working concentration 
of kanamycin (KAN) used is 50 µg/mL and tetracycline (TET) is 12.5 µg/mL. 
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For BL21-Gold (DE3) cultures, 10 mL starter cultures innoculated with single colonies 
were grown in LB broth media supplemented with appropriate antibiotics. The starter culture was 
grown at 37°C with 250 rpm shaking overnight. A 1 mL freezer stock in 15% glycerol was prepared 
as described previously and immediately stored at -80°C. A 1 L volume culture was grown by 
innoculating 1 L of LB broth with 10 mL of the starter culture and adding the appropriate antibiotics. 
The culture was grown at 37°C on an orbital shaker at 250 rpm until the optical density of the cells 
at 600 nm absorbance (OD600) reached 0.5 – 0.6. The culture was induced with 0.4 mM IPTG and 
incubated overnight at 16°C or for 3 hours at 37°C.   
For Shuffle T7 Express and Shuffle T7 Express lysY cultures, 10 mL starter cultures were 
grown in LB broth media supplemented with appropriate antibiotics by selecting a single colony 
from a freshly grown plate (either a new transformation or a freezer stock). The starter cultures 
were grown at 30°C with 250 rpm shaking overnight. Freezer stocks in 15% glycerol were 
prepared as described previously and immediately stored at -80°C. A 1 L volume culture was 
grown by innoculating 1 L of LB broth with 10 mL of the starter culture and adding the appropriate 
antibiotics. The cultures were grown at 30°C with 250 rpm shaking until the OD600 reached 0.4 – 
0.5. The cultures were then induced with 0.4 mM IPTG and incubated overnight at 16°C or for 4 
to 6 hours at 30°C. 
For each expression, 1 mL samples of the culture were collected before and after induction 
for SDS-PAGE analysis. The cells were spun down at 4000 x g for 5 min on a benchtop centrifuge 
and the supernatant was discarded. The cell pellets were frozen at -20°C until sample preparation 
for analysis. 
The 1 L cultures were harvested by centrifugation at 4000 x g for 10 min at 4°C using a 
Thermo Scientific Sorvall RC 6+ centrifuge with a FIBERLite F9-4x1000y rotor. The supernatant 
was discarded and the pellets were stored at -80°C until lysis. 
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Table 6. Recipe for 1 liter 10x M9 Salts. 
Na2HPO4•7H2O 128 g 
KH2PO4 30 g 
NaCl 5 g 
 
Table 7. Recipe for 100 mL 1000x Trace Minerals (10 mM each). 
FeCl3•6H2O 0.2703 g 
CuSO4•5H2O 0.2497 g 
MnSO4•H2O 0.1690 g 
ZnSO4•7H2O 0.2875 g 
 
Table 8. Recipe for 1 liter 200x Vitamins. 
0.1% Thiamin hydrochloride 1 g 
0.02% Biotin 200 mg 
0.02% Choline chloride 200 mg 
0.02% Folic acid 200 mg 
0.02% Nicotinamide 200 mg 
0.02% D-Pantothenic acid hemicalcium salt 200 mg 
0.02% Pyridoxal hydrochloride 200 mg 
0.002% Riboflavin 20 mg 
 
Table 9. Recipe for 1 liter Minimal media. 
10x M9 Salts 100 mL 
1 M MgSO4 2 mL 
200x Vitamins 5 mL 
1000x Trace Minerals 1 mL 
D-Glucose monohydrate 4 g 
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 Table 9 continued 
 
2.2.4 Cell Lysis and Protein Purification 
Cells were lysed with 20 mL of lysis buffer (50 mM Tris, pH 6.9, 1 mM PMSF, 2 mL of 10x 
Bugbuster, and 20 μL Benzonase nuclease) followed by four cycles of mechanical lysis in a 
French press at 1,000 psi. The cell lysate was centrifuged at 30,000 x g for 30 minutes at 4°C 
using a Thermo Scientific Sorvall RC 6+ centrifuge with a FIBERLite F21-8x50y rotor. The 6X-
His-tagged protein was purified from the cleared lysate with a Profinity IMAC Ni affinity 
chromatography column (4 mL) followed by desalting using a P-4 gel column or gel filtration/size-
exclusion chromatography column (Hi-Prep 26/60 Sephacryl S-100 HR or ENrich SEC 70). The 
equilibration/wash buffer used for the IMAC column was 25 mM Tris, 0.5 M NaCl, 10 mM 
imidazole, pH 6.9 and the elution buffer was 25 mM Tris, 0.5 M NaCl, 500 mM imidazole, pH 6.9. 
The buffer used for the P-4 gel or gel filtration chromatography was 25 mM Tris, 150 mM NaCl, 
pH 6.9. 
2.2.5 SDS-PAGE Gel Electrophoresis 
The cell pellet samples from a culture and protein obtained after chromatographic 
purification were analyzed using sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE). The cell pellet sample was resuspended completely in 50 μL of Millipore water, and 
about 1-15 μL of the mixture was used as a sample for SDS-PAGE analysis. The samples for 
SDS-PAGE using a Bio-Rad 4-20% TGX precast gels were prepared by mixing the sample and 
sample loading buffer in a 1:1 ratio. The sample loading buffer was prepared fresh each time by 
mixing 5% v/v βME to 95% v/v 2x Laemmli sample buffer. The samples for SDS-PAGE using a 
15N labeled NH4Cl 1 g 
Kanamycin (50 mg/mL) 1 mL 
0.1 M CaCl2 1 mL 
Innoculum 10 mL 
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Bio-Rad 10-20% Tris-Tricine precast gels were prepared by mixing the sample and sample 
loading buffer in a 1:2 ratio. The sample loading buffer was prepared fresh each time by mixing 
2% v/v βME to 98% v/v Tricine sample buffer. The samples were heated at 95°C for 15 minutes 
and centrifuged briefly before loading into the gel well. The SDS-PAGE was run on a Bio-Rad gel 
electrophoresis kit at a constant voltage setting of 125V for 60 minutes with 25 mM Tris, 192 mM 
glycine, 0.1% SDS, pH 8.3 for the 4-20% TGX gels and 100 mM tris, 100 mM tricine, 0.1% SDS, 
pH 8.3 for the tris-tricine gels.  After the electrophoresis is complete, the gels were removed from 
the plastic cassette housing and stained with 10 mL of Coomassie stain solution (0.1% w/v 
Coomassie brilliant blue R 250 in 50% methanol, 40% water and 10% acetic acid) with a constant 
shaking for 1 hour at room temperature followed by rinsing in a destain solution (50% methanol, 
40% water and 10% acetic acid) for 2 hours. 
2.2.6 Reversed-phase HPLC 
The properly folded and mis-folded protein was separated by purification using a reverse-
phase high performance liquid chromatography (RP-HPLC) column (Purity Semi-Prep HPLC C18 
column). A linear gradient from 0 to 75% solvent B (100% acetonitrile containing 0.1% TFA) in 
solvent A (water with 0.1% TFA) for 45 minutes at 2 mL/min flow rate was applied for eluting the 
protein from the column. The eluted protein was monitored at 214 and 280 nm absorbance. 
Fractions of eluents from individual peaks were collected and dried on a Speed-Vac (Thermo 
Savant SPD121 with UVS 400). All the significant peaks observed on RP-HPLC were analyzed 
by Bruker UltrafleXtreme MALDI-TOF/TOF mass spectrometry to confirm the molecular weight of 
the purified protein. 
2.2.7 MALDI Mass Spectrometry 
The protein obtained from RP-HPLC was analyzed using matrix-assisted laser 
desorption/ionization (MALDI) time of flight (TOF) mass spectrometry (MS). The MALDI matrix 
was prepared by mixing 30 mg of sinapinic acid in 1 mL of 30% acetonitrile, 70% water, and 0.1% 
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v/v TFA. The matrix solution was mixed using vortex for 10 minutes and centrifuged to separate 
the supernatant. MALDI samples were prepared by mixing 1 μL of purified protein sample with 1 
μL of sinapinic acid matrix. In general, 10-50 pmol/µL protein sample is sufficient for MALDI 
analysis of proteins with molecular weights greater than 1 kDa and less than 20 kDa.38 1 μL of 
the sample mixture was pipetted on a MALDI target plate (Bruker Daltonics MTP 384 massive 
target T) and allowed to air dry. The sample spot on the target plate was analyzed with a Bruker 
UltrafleXtreme MALDI-TOF/TOF MS in the LSU Mass Spectrometry Facility. Spectra were 
recorded in positive ion linear mode with an ion acceleration potential of 25 kV. The ionization 
was performed using a Nd:YAG laser with 355 nm wavelength and 3 ns pulse. Laser shots (6500 
shots) were summed together to generate each spectrum. The spectra were recorded in the mass 
range of 4000–25000 Da. 
2.2.8 Coomassie (Bradford) Protein Assay 
 The protein concentration after chromatographic purification was measured using 
Coomassie Plus (Bradford) protein assay reagent. The samples were prepared in a UV 
transparent 96-well plate. A standard curve plot was drawn using a series of bovine serum 
albumin (BSA) standards at varying concentrations. The absorbance of each BSA samples was 
measured at 595 nm using a UV/vis spectrophotometer (BioTek PowerWave XS2) and plotted 
against the known concentration of BSA. The resulting line was fitted using the least squares 
method, and the final concentration of the unknown protein sample was calculated. The volume 
of each reagent used to make a standard curve plot is listed in Table 10. 
Table 10. Volume of reagents needed to plot a standard curve for Coomassie protein assay. 
 Volume in µL 
Coomassie Reagent 200 200 200 200 200 200 
Protein Elution Buffer 50 40 30 20 10 40 
BSA Standard 
(40 µg/mL) 
0 10 20 30 40 0 
Protein Sample 0 0 0 0 0 10 
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2.2.9 1H-15N HSQC NMR to Detect Protein Folding and Assignments 
1H-15N Heteronuclear single quantum coherence (HSQC) NMR spectroscopy was used to 
determine the foldedness of the protein. In order to obtain a good HSQC NMR signal, about 1 
mM of the protein is needed. For example, for the EGF27 protein with a molecular weight of 7.1 
kDa, nearly 2 mg of pure protein is needed to make 1 mM concentration in a 250 μL sample 
volume. The NMR sample for EGF27 protein was prepared in 10 % D2O and 90% H2O. 0.5 μL of 
1% (w/v) DSS in D2O standard was added for chemical shift referencing. The sample was 
transferred into a 5 mm Shigemi tube for running the NMR experiments. The NMR spectra were 
collected on a Varian 700 MHz spectrometer with a 5-mm-HCN-5922 probe at the LSU NMR 
Facility. A gNhsqc (sensitivity enhanced gradient 1H-15N HSQC) experiment was run with 16 
scans and 256 increments. The 2D HSQC spectrum was processed on a Linux operating system 
using NMRPipe39 software developed by the National Institute of Health. NMRView40 software 
was used to visualize the spectra. 
2.3 Results and Discussion 
EGF constructs used in our study are listed in Table 11 with their antibiotic resistance, 
properties, and the E. coli strains used for protein expression. The amino acid sequences of the 
expressed proteins and their molecular weights are listed in the appendix. 
Table 11. Various EGF constructs with their properties. 
Protein 
expressed 
Plasmid name 
Antibiotic 
resistance 
Properties 
Expression 
E. coli strain 
EGF26-27-28-
6XHis 
pET28b-EGF26-
27-28 
Kan 
With a C-terminal His-
tag 
BL21-
Gold(DE3) 
EGF25-26-27-
6XHis 
pET28b-EGF25-
26-27 
Kan 
With a C-terminal His-
tag 
BL21-
Gold(DE3) 
EGF25-26-
C21G-6XHis 
pET28a-EGF25-
26-C21G 
Kan 
EGF25-26 construct with 
an extra cysteine 
mutated to glycine; 
consists a C-terminal 
His-tag 
BL21-
Gold(DE3) 
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Table 11 continued 
Protein 
expressed 
Plasmid name 
Antibiotic 
resistance 
Properties 
Expression 
E. coli strain 
EGF25-26-
C21G-TEV-
EGFP-6XHis 
pLIC-EGF25-26-
C21G-TEV-
EGFP-His 
Kan 
Green fluorescent 
protein fusion with a TEV 
cleavage site with C-
terminal His-tag; an extra 
cysteine mutated to 
glycine 
BL21-
Gold(DE3), 
Shuffle T7 
Express 
pelB-EGF27-
TEV-EGFP-
6XHis 
pLIC-pelB-
EGF27-TEV-
EGFP-His 
Kan 
Green fluorescent 
protein fusion with a TEV 
cleavage site with C-
terminal His-tag 
BL21-
Gold(DE3), 
Shuffle T7 
Express 
EGF27-TEV-
EGFP-6XHis 
pLIC-EGF27-
TEV-EGFP-His 
Kan 
Green fluorescent 
protein fusion with a TEV 
cleavage site with C-
terminal His-tag 
BL21-
Gold(DE3), 
Shuffle T7 
Express 
EGF27-6XHis 
pET28a-EGF27 
(without pelB) 
Kan With a C-terminal His-tag 
BL21-
Gold(DE3), 
Shuffle T7 
Express, 
Shuffle T7 
Express lysY 
 
2.3.1 Expression and Purification 
EGF26-27-28: 
EGF26-27-28-6XHis (EGF26-28) was expressed at 16°C overnight after induction with 0.5 
mM IPTG in BL21-Gold(DE3) competent E. coli cells using the pET28b-EGF26-27-28 vector. The 
expression culture was analyzed by SDS-PAGE gel electrophoresis (Figure 7) to monitor 
expression levels. The molecular weight of EGF26-28 is 14.1 kDa. The first lane in Figure 7 is a 
protein molecular weight marker, or the ladder, which is used for referencing the bands on the 
gel. The second lane is the whole cell sample before inducing the culture with IPTG. This lane 
serves as a background when analyzing protein being produced over time after induction. Lanes 
3-6 are the whole cell samples after the culture was induced with IPTG. Lane 6 is the sample 
before harvesting the culture, which shows a significant dark band just above 15 kDa (marked by 
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an asterisk). This band suggests that EGF26-28 is being abundantly produced, or overexpressed, 
compared to the background E. coli proteins.  
EGF26-28 was purified from the cleared lysate using Profinity IMAC nickel affinity 
chromatography (Figure 8a) followed by gel filtration chromatography using a Hi-Prep 26/60 
Sephacryl S-100 HR column (Figure 8b). The large elution profile with a sharp peak in Figure 8 
(a) between 40 and 60 mL shows that the eluted protein from the Ni-affinity column is abundant. 
Figure 8 (b) shows the gel filtration chromatogram, which consists of two eluted peaks. Based on 
separations performed with molecular weight standards, the first eluting large peak at 140 mL 
(peak 1) is protein with relatively high molecular weight (>100 kDa). The second peak at 220 mL 
(peak 2) is consistent with the elution of monomeric EGF26-28.  
Figure 7. SDS-PAGE gel image of EGF26-28 expression culture. Samples include time point 
before induction (lane 2) and after induction (lane 3 = 1h, lane 4 = 2h, lane 5 = 3h, and lane 6 = 
overnight or approximately 16h). 
Lanes:   1         2        3       4        5          6 
* 
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The elution fractions of EGF26-28 from Ni-affinity and gel filtration chromatography were 
analyzed with SDS-PAGE. Samples were prepared with and without βME to evaluate the extent 
of intermolecular cross-linking. If the disulfide bonded protein gives a clear band at approximately 
the correct molecular weight in the absence of βME, then we can deduce that the protein is not 
cross-linked by erroneous intermolecular disulfide bonds. If a smear is observed throughout the 
lane instead of a clear band, then the protein is most likely cross-linked and in multimeric form. 
Figure 8 (c) shows the SDS-PAGE gel image of the Ni-elution with and without βME (lanes 2 and 
3), peak 1 with and without βME (lanes 4 and 5), and peak 2 with and without βME (lanes 6 and 
7). From the gel image in Figure 8 (c), it is clear that the IMAC elution sample is a mixture of 
monomer EGF26-28 and cross-linked protein (lanes 2 and 3). The monomeric protein and cross-
linked protein can be separated by gel filtration. Peak 1 is mostly cross-linked (lane 5). We can 
further deduce from the gel image that peak 2 is the monomeric form of the protein, which is 
Figure 8. (a) Profinity IMAC nickel affinity chromatography purification of EGF26-28. (b) Size-
exclusion chromatography (SEC) purification of the IMAC eluted EGF26-28. Two peaks elute at 
140 mL (peak 1) and 220 mL (peak 2). (c) SDS-PAGE gel image of the IMAC and SEC purified 
EGF26-28 with and without βME: lane 1 (protein ladder), lane 2-3 (IMAC elution), lane 4-5 (SEC 
peak 1), and lane 6-7 (SEC peak 2). 
Lanes:    1        2          3         4       5         6                                       7 
* 
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confirmed by a single band (lane 7). Although we were able to produce the monomeric form of 
the protein, the quantity that was produced was too low for NMR studies. 
EGF25-26-27: 
EGF25-26-27-6XHis (EGF25-27) was expressed at 16°C overnight after induction with 0.5 
mM IPTG in BL21-Gold(DE3) E. coli cells using the pET28b-EGF25-26-27 vector. Figure 9 shows 
the SDS-PAGE gel image of the expression culture to monitor expression levels. The molecular 
weight of EGF25-27 is 13.8 kDa. As compared to the background E. coli proteins on the gel 
image, it appears that EGF25-27 did not express in overabundance. Figure 10 (a) and (b) shows 
the IMAC and gel filtration chromatograms, respectively. Figure 10 (c) and (d) shows the SDS-
PAGE gel images of the chromatographic samples. In Figure 10 (a), the elution profile indicates 
a high yield, but the SDS-PAGE in Figure 10 (c) shows a mixture of many different proteins 
indicating that EGF25-27 was produced in low yield, if at all. The gel filtration absorbance 
maximum in Figure 10 (b) confirms the low protein yield, and the multiple peaks confirm a mixture 
of proteins. Peak 4, which elutes where the monomeric EGF25-27 is expected, runs at a higher 
Figure 9. SDS-PAGE gel image of EGF25-27 expression culture. Samples include time point 
before induction (lane 2) and after induction (lane 3 = 1h, lane 4 = 2h, lane 5 = 3h, and lane 6 = 
overnight or approximately 16h). 
Lanes:       1          2        3         4            5          6 
* 
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MW on SDS-PAGE (Figure 10d), even with βME (lane 2). These results indicate that EGF25-27 
does not express well in BL21-Gold(DE3) cells.    
 
EGF25-26-C21G: 
EGF25-26-C21G-6XHis (EGF25-26) was expressed at 20°C overnight after induction with 
0.5 mM IPTG in BL21-Gold(DE3) E. coli cells using the pET28a-EGF25-26-C21G vector. The 
molecular weight of EGF25-26-C21G is 8.99 kDa. Figure 11 shows the SDS-PAGE gel image of 
the expression culture, which indicates that EGF25-26 did not express in abundance. Figure 12 
(a) and (b) shows the IMAC and gel filtration chromatograms, respectively. The elution profile 
from the IMAC chromatogram suggests that the protein is in high yield. Figure 12 (b) shows the 
gel filtration elution profiles with two peaks. Peak 2, eluting at 225 mL, appears to be a monomer 
based on the elution profile of the standards. Figure 12 (c) and (d) shows the SDS-PAGE gel 
Figure 10. (a) Profinity IMAC nickel affinity chromatography purification of EGF25-27. (b) Size-
exclusion chromatography (SEC) purification of the IMAC eluted EGF25-27. Multiple peaks elute 
between 100-300 mL. (c) SDS-PAGE gel image of the IMAC purified EGF25-27 with βME: lane 
1 (protein ladder) and lane 2 (IMAC elution). (d) SDS-PAGE gel image of the SEC purified EGF25-
27 with and without βME: lane 1 (protein ladder), lane 2-3 (SEC peak 4 at 230 mL). 
Lanes:    
         1         2 
Lanes:    
         1         2        3 
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images of the chromatographic samples. The IMAC elution sample in Figure 12 (c) in the absence 
Lanes:    1           2          3          4          5 
* 
Lanes:  1      2        3        4       5 Lanes: 1    2         3 
* * 
* 
Figure 11. SDS-PAGE gel image of EGF25-26-C21G expression culture. Samples include time 
point before induction (lane 2) and after induction (lane 3 = 1h, lane 4 = 3h, and lane 5 = overnight 
or approximately 16h). 
Figure 12. (a) Profinity IMAC nickel affinity chromatography purification of EGF25-26-C21G. (b) 
Size-exclusion chromatography (SEC) purification of the IMAC eluted EGF25-26-C21G. Two 
peaks elute at 145 mL (peak 1) and 225 mL (peak 2). (c) SDS-PAGE gel image of IMAC purified 
EGF25-26-C21G with and without βME: lane 1 (protein ladder) and lane 2-3 (IMAC elution). (d) 
SDS-PAGE gel image of SEC purified EGF25-26-C21G with and without βME: lane 1 (protein 
ladder), lane 2-3 (SEC peak 1), and lane 4-5 (SEC peak 2). 
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of βME (lane 3) appears as a smear with a band at about 15 kDa (marked by an asterisk). After 
gel filtration purification, peak 1 samples (Figure 12b) on SDS-PAGE (Figure 12d) look like a 
mixture of cross-linked protein (MW ~75 kDa) and monomeric EGF25-26. The band observed 
near 15 kDa is not a dimer because the MW is below 18 kDa, so it is most likely monomeric 
EGF25-26. Therefore, peak 2 sample is most likely the monomeric EGF25-26. 
EGF25-26-C21G-TEV-EGFP: 
EGF25-26-C21G-TEV-EGFP-6XHis (EGF25-26-EGFP) was expressed at 16°C overnight 
after induction with 0.5 mM IPTG in BL21-Gold(DE3) and Shuffle T7 Express E. coli cells using 
the pLIC-EGF25-26-C21G-TEV-EGFP-His vector. Figure 13 (a) and (b) are the SDS-PAGE gel 
images of the cultures in BL21-Gold(DE3) and Shuffle T7 Express cells, respectively, showing 
the expression levels in the cultures. The molecular weight (MW) of the EGF25-26-EGFP fusion 
Figure 13. SDS-PAGE gel images of EGF25-26-EGFP expression cultures. (a) Expressions in 
BL21-Gold(DE3) cells. Samples include time points before induction (lane 2 and 4) and after 
induction (lane 3 = 3h at 37°C, lane 5 = 3h at 16°C, and lane 6 = overnight or approximately 16h 
at 16°C). (b) Expressions in Shuffle T7 Express cells. Samples include time points before 
induction (lane 2 and 4) and after induction (lane 3 = 6h at 30°C, lane 5 = 6h at 16°C, and lane 6 
= overnight or approximately 16h at 16°C). The asterisk indicates overexpression of the protein. 
(a) (b) 
* 
Lanes:  1          2            3          4           5            6  
Lanes:  1          2          3            4            5           6  
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protein is 38.5 kDa. After cleavage by TEV protease, the MW of EGF25-26-C21G is 10.6 kDa and 
the EGFP-His is 27.9 kDa. As compared to the background E. coli proteins on the gel image in 
Figure 13 (b), the fusion protein is seen to be overexpressed (marked by an asterisk). Shuffle cell 
expressions at 30°C for 6 hours after induction with IPTG had the highest expression level of 
EGF25-26-EGFP and was selected for further purification and analysis. Although the MW of the 
fusion protein is 38.5 kDa, the dark band of the expressed protein on the gel is seen a little below 
the 37 kDa marker. This difference in migration is not unusual because the way a protein migrates 
on a gel depends on its shape and net charge. 
Figure 14 (a) shows the IMAC chromatogram of EGF25-26-EGFP purification from Shuffle 
T7 Express E. coli cells. Figure 14 (b) shows the SDS-PAGE gel image of the IMAC eluted 
samples in lane 2 and the reaction with TEV protease (AcTEV) in lane 3. 1 μL of AcTEV protease 
(10 units) was added to 30 μg of IMAC purified fusion protein and incubated for 16 hours at 30°C. 
There were two resulting bands observed after TEV cleavage, a darker band between 25-30 kDa 
Figure 14. (a) Profinity IMAC nickel affinity chromatography purification of EGF25-26-EGFP fusion 
protein in Shuffle T7 Express cells. (b) SDS-PAGE gel image of the IMAC purification: lane 1 
(protein ladder), lane 2 (IMAC elution of the fusion protein sample), and lane 3 (IMAC elution 
sample reaction with AcTEV protease). 
(b) 
* 
* 
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and a faint band between 10-15 kDa (marked by asterisks) with respect to the protein ladder on 
the gel. The band between 25-30 kDa is most likely EGFP-His after TEV cleavage from the fusion 
protein, and the band between 10-15 kDa is probably our target protein EGF25-26-C21G. These 
observations confirm that AcTEV is cleaving the fusion protein at the TEV cleavage site, however 
the target protein (EGF25-26-C21G) is not being produced as much. The protein did not 
noticeably precipitate during the purification steps. Thus, the reason for not being able to get 
enough yield of the target protein after TEV cleavage, despite having success in producing the 
fusion protein in high yield, is not known.  
EGF27-TEV-EGFP: 
EGF27-TEV-EGFP-6XHis (EGF27-EGFP) was expressed at 16°C overnight after 
induction with 0.5 mM IPTG in BL21-Gold(DE3) and Shuffle T7 Express E. coli cells using the 
pLIC-EGF27-TEV-EGFP-His vector. Figure 15 (a) and (b) are the SDS-PAGE gel images of the 
cultures in BL21-Gold(DE3) and Shuffle T7 Express cells, respectively, showing the expression 
levels in the cultures. The MW of the EGF27-EGFP fusion protein is 35.5 kDa. After TEV 
cleavage, the MW of EGF27 is 7.5 kDa and the EGFP-His is 27.9 kDa. As compared to the 
background E. coli proteins on the gel image in Figure 15, the fusion protein is seen to be 
overexpressed (marked by an asterisk). BL21-Gold(DE3) cell expressions overnight at 16°C after 
induction with IPTG had the highest expression of pLIC-EGF27-TEV-EGFP-6XHis protein and 
was selected for further purification and analysis. 
Figure 16 (a) shows the IMAC chromatogram of EGF27-EGFP purification in BL21-
Gold(DE3) E. coli cells. Figure 16 (b) shows the SDS-PAGE gel image of the IMAC elutions with 
two dark bands (marked by an asterisk), one above and one below the 30 kDa marker. The band 
above 30 kDa is most likely the fusion protein, and the one below is likely EGFP-His. The 
(b) 
Lanes:   1        2                      3 
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observance of two bands without the addition of TEV protease is quite unusual and indicates that 
Figure 16. (a) Profinity IMAC nickel affinity chromatography purification of EGF27-EGFP in BL21-
Gold(DE3) E. coli cells. The absorbance signal was cut-off between 2 to 2.5 AU, so the signal 
observed up to 5 AU was possibly due to a problem with the new UV lamp. (b) SDS-PAGE gel 
image of the IMAC purified EGF27-EGFP. 
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Figure 15. SDS-PAGE gel images of EGF27-EGFP expression cultures. (a) Expressions in BL21-
Gold(DE3) cells. Samples include time points before induction (lane 2) and after induction (lane 
3 = 3h at 37°C, lane 4 = 3h at 16°C, and lane 5 = overnight or approximately 16h at 16°C). (b) 
Expressions in Shuffle T7 Express cells. Samples include time points before induction (lane 1 and 
3) and after induction (lane 2 = 6h at 30°C, lane 4 = 6h at 16°C, and lane 6 = overnight or 
approximately 16h at 16°C). The asterisk indicates overexpression of the protein. 
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the fusion protein is being cleaved by an E. coli protease.  
Figure 17 shows the SDS-PAGE gel image of EGF27-EGFP fusion protein reaction with 
TEV protease (AcTEV). 10 μL of AcTEV protease (100 units) was added to 300 μg of the fusion 
protein and incubated at 30°C for 16 hours. Ni Sepharose 6 Fast Flow affinity chromatography 
purification by gravity flow was performed, and the flow-through, washes, and elution samples 
were analyzed by SDS-PAGE. TEV protease cleaves the fusion protein into EGF27 and EGFP-
His proteins. EGFP-His has a 6X histidine tag, which has an affinity for nickel and thus binds to 
the nickel media. EGF27, which is our target protein, does not have any affinity tags attached to 
it after TEV cleavage, so it does not bind to the nickel media. EGFP-His is eluted from the nickel 
media by passing buffer containing (~0.5 M) imidazole. The gel image in Figure 17 indicates that 
the TEV cleavage reaction worked, which is shown by the appearance of a dark band between 
25 and 30 kDa in the elution samples (lanes 6-9, marked by an asterisk). The band at 30 kDa in 
the elution samples is uncleaved protein, indicating that the TEV protease does not cleave this 
fusion protein very efficiently. The appearance of a faint band around 10 kDa in the flow-through 
Figure 17. SDS-PAGE gel image of the nickel affinity chromatography gravity purification of pLIC-
EGF27-TEV-EGFP-His after TEV cleavage using AcTEV protease. Lane 1 and 10 (protein 
ladder), lane 2-3 (flow-through with and without βME), lane 4-5 (washes), and lane 6-9 (elutions). 
* 
Lanes:    1             2            3           4            5           6            7            8            9           10 
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sample (FT) is the target protein (EGF27). The amount of EGF27 produced by this method is very 
low and does not produce enough protein for NMR studies. 
pelB-EGF27-TEV-EGFP: 
pelB-EGF27-TEV-EGFP-6XHis (pelB-EGF27-EGFP) was expressed at 16°C overnight 
after induction with 0.5 mM IPTG in BL21-Gold(DE3) and Shuffle T7 Express competent E. coli 
cells using the pLIC-pelB-EGF27-TEV-EGFP-His vector. Figure 18 (a) and (b) are the SDS-PAGE 
gel images of the cultures in BL21-Gold(DE3) and Shuffle T7 Express cells, respectively, showing 
the expression level of the cultures. The MW of the pelB-EGF27-EGFP fusion protein is 38.7 kDa 
before the periplasmic proteolytic digestion of the pelB leader sequence. After pelB digestion, the 
MW of the fusion protein is 35.5 kDa. After TEV cleavage, the MW of EGF27 without pelB is 7.5 
kDa, EGF27 with pelB is 10.7 kDa, and the EGFP-His is 27.9 kDa. As compared to the 
Figure 18. SDS-PAGE gel images of pelB-EGF27-EGFP expression cultures. (a) Expressions in 
BL21-Gold(DE3) cells. Samples include time points before induction (lane 2) and after induction 
(lane 3 = 3h at 37°C, lane 4 = 3h at 16°C, and lane 5 = overnight or approximately 16h at 16°C). 
(b) Expressions in Shuffle T7 Express cells. Samples include time points before induction (lane 
2) and after induction (lane 3 = 6h at 30°C, lane 4 = 6h at 16°C, and lane 5 = overnight or 
approximately 16h at 16°C). The asterisk indicates overexpression of the protein. 
(a) (b) 
Lanes:    1           2             3            4               5 
Lanes:    1             2             3           4              5 
* * 
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background E. coli proteins on the gel image in Figure 18 above, the fusion protein is seen to be 
overexpressed (marked by an asterisk). BL21-Gold(DE3) cell expressions at 37°C for 3 hours 
and Shuffle cell expressions at 30°C for 6 hours after induction with IPTG had the highest 
expression of pelB-EGF27-TEV-EGFP-6XHis protein. The dark band of the expressed protein on 
the gel is seen a little below the 37 kDa marker. The gel migration of EGF27-EGFP in Figure 15 
should be the same as in Figure 18, if the pelB leader sequence is cleaved in vivo. The migration 
is clearly different, ~35 kDa in Figure 18 and ~31 kDa in Figure 15, indicating that pelB-EGF27-
EGFP is cleaved in the periplasm in vivo. Because the pelB sequence was not cleaved, the protein 
was not purified. 
EGF27 sub-cloning and expression: 
EGF27 was sub-cloned from the pET20b-pelB-EGF27-6XHis plasmid into the pET-28a 
plasmid at restriction sites NcoI and XhoI to make pET28a-EGF27-6XHis. Because a one-pot 
cloning reaction was used, the possible ligation products include the desired pET28a-EGF27 and 
the undesired empty pET-28a, pET20b-EGF27, and pET20b-pET28a hybrid. The post-ligation 
reaction with NdeI linearizes the undesired products, reducing the number of ligation-competent 
plasmid. Growing the transformed cells on agar plates with kanamycin selects for colonies 
transformed with either pET28a-EGF27-6XHis or empty pET-28a. pET 3’ and pET 5’ primers were 
used to amplify the plasmid from individual colonies by polymerase chain reaction (PCR). The 
amplification product from pET28a-EGF27-6XHis is 357 base pairs (bp) and from empty pET-28a 
is 313 bp. DNA agarose gel electrophoresis analysis of the PCR products (Figure 19) show that 
colonies C#1, C#2, C#3, C#4, and C#8 produce bands between 300-400 bp (marked by an 
asterisk) near the desired product size of 357 bp. Plasmid was purified from C#8, sequenced by 
the GeneLab at the LSU School of Veterinary Medicine, and verified to be pET28a-EGF27-6XHis. 
 
 
* 
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Figure 20. SDS-PAGE gel image of EGF27 expression culture in LB media; expressions in Shuffle 
T7 Express cells. Samples include time points before induction (lane 2) and after induction (lane 
3 = 3h at 30°C, and lane 4 = 6h at 30°C). 
Figure 19. DNA agarose gel electrophoresis showing colony PCR of the sub-cloned pET28a-
EGF27 plasmid. Lane 1 (empty pET-28a vector plasmid, control), lane 2 (pET20b-pelB-EGF27, 
control), lane 3 (2-log DNA ladder), lane 4-9 (individual colonies selected from the transformation 
plate of the sub-cloned pET28a-EGF27 plasmid). 
Lanes:     1            2             3             4 
* 
* 
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pET28a-EGF27-6XHis (EGF27) was expressed in LB and minimal media at either 30°C 
for 4-6h or 16°C overnight after induction with 0.4 mM IPTG in BL21-Gold(DE3), Shuffle T7 
Express,  and Shuffle T7 Express lysY E. coli cells using the pET28a-EGF27 vector. Figure 20 
shows the SDS-PAGE gel image of the culture in Shuffle T7 Express cells (expressions in LB 
media), showing the expression level of the culture. The molecular weight of EGF27 is 7.1 kDa. 
Looking at the results from the gel, the slightly darker band after 6h of induction (marked by an 
asterisk) maybe over-expressed EGF27-6XHis.  
Figure 21 (a), (b) and (c) shows the SDS-PAGE gel images of the cultures in BL21-
Gold(DE3), Shuffle T7 Express, and Shuffle T7 Express lysY cells, respectively (expressions in 
15N labeled minimal media). The slightly darker bands after 4h of induction (marked by asterisks) 
maybe EGF27-6XHis.  
 
Figure 21. SDS-PAGE gel images of EGF27 expression cultures in 15N labeled minimal media. 
(a) Expressions in BL21-Gold(DE3) cells. Samples include time points before induction (lane 2) 
and after induction (lane 3 = 3h at 16°C, and lane 4 = overnight or approximately 16h at 16°C). 
(b) Expressions in Shuffle T7 Express cells. Samples include time points before induction (lane 
2) and after induction (lane 3 = 1h, lane 4 = 2h, lane 5 = 3h, and lane 6 = 4h at 30°C). (c) 
Expressions in Shuffle T7 Express lysY cells. Samples include time points before induction (lane 
2) and after induction (lane 3 = 1h, lane 4 = 2h, lane 5 = 3h, and lane 6 = 4h at 30°C). 
(a) (b) (c) 
Lanes:      1           2              3        4            5        6 
Lanes:     1           2         3         4          5           6 
Lanes:    1          2          3          4 
* * 
* 
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Figure 22 (a) shows the IMAC chromatography purification of 15N labeled EGF27 in BL21-
Gold(DE3) purification. Figure 22 (b) shows the SDS-PAGE gel image of the elution sample with 
and without βME, lanes 2 and 3, respectively. The IMAC elution sample, in the absence of βME, 
appears as a smear throughout the lane with a faint band a little above the 10 kDa marker. This 
smear suggests that most of the protein is in multimeric form and highly cross-linked with 
intermolecular disulfide bonds. 
Figure 22. (a) Profinity IMAC nickel affinity chromatography purification of EGF27 in BL21-
Gold(DE3) cells expressed in 15N labeled minimal media. The absorbance signal was cut-off 
between 2 to 2.5 AU, so the signal observed up to 5 AU was possibly due to a problem with the 
new UV lamp. (b) SDS-PAGE gel image of IMAC purified EGF27 with βME (lane 2) and without 
βME (lane 3). 
Figure 23. (a) Profinity IMAC nickel affinity chromatography purification of EGF27 in Shuffle T7 
Express cells expressed in LB media. (b) Bio-Rad ENrich SEC 70 gel filtration chromatography 
purification of the IMAC purified EGF27 sample. 
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Figure 23 (a) shows the IMAC chromatography purification of EGF27-6XHis from a culture 
of Shuffle T7 Express in LB media. The chromatogram shows that the eluted protein (40 mL) is 
in low abundance. The protein concentration was determined using the Coomassie (Bradford) 
protein assay, and the yield was found to be 1.45 mg. The IMAC elutions were concentrated to 
about 2 mL using an Amicon 3 kDa molecular weight cut-off (MWCO) centrifugal filter unit and 
desalted using a Bio-Rad P-4 column. The protein yield after desalting (20 mM MES, 100 mM 
NaCl, pH 6.5 buffer) was determined again and was found to be 240 μg. The protein was likely 
lost through precipitation while concentrating the samples in the centrifugal filter. Figure 23 (b) 
shows the gel filtration chromatography analysis of the IMAC purified EGF27 sample using a Bio-
Rad ENrich SEC 70 gel filtration column. For this analysis, 250 μL containing 120 μg of IMAC 
eluted protein was injected onto the gel filtration column. Two peaks eluted and each of these 
were analyzed by SDS-PAGE.  
Figure 24 (a) shows the SDS-PAGE gel image of the sample eluted from the IMAC column 
(Figure 23 (a)) with and without βME. Figure 24 (b) shows the SDS-PAGE of the samples from 
the gel filtration column (Figure 23 (b)). Lanes 2-3 in Figure 24 (b) are the peak 1 samples of 
Figure 24. SDS-PAGE gel images of the EGF27 purification with and without βME using (a) 
Profinity IMAC and (b) ENrich SEC 70. 
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Figure 23 (b) with and without βME. Peak 1 is mostly a higher molecular weight protein (~60 kDa). 
Lanes 4-5 are the peak 2 samples with and without βME. The dark band of the protein appears a 
little below the 10 kDa marker both in the absence and presence of βME (Figure 24 (b)). The gel 
filtration and SDS-PAGE results taken together suggest that peak 2 in the gel filtration 
chromatogram is EGF27 in its monomeric form and is not cross-linked. The molecular weight of 
the sample was further confirmed by MALDI MS (discussed in section 2.3.3). Additionally, the 
folding isoforms of this protein was further analyzed using RP-HPLC (discussed in section 2.3.2).  
Figure 25 (a) and (b) shows the IMAC and gel filtration chromatograms from purification 
of EGF27-6XHis Shuffle T7 Express lysY cells cultured in LB media. Peak 2 on the chromatogram 
in Figure 25 (b) was confirmed to be monomeric EGF27-6XHis by SDS-PAGE analysis and 
MALDI MS. The monomeric EGF27-6XHis (peak 2 elution) concentration was determined using 
Coomassie protein assay and the yield was found to be 100 μg, which was similar to the yield 
from Shuffle T7 Express cells. The reason for such a low yield in the end was because the protein 
was lost while concentrating using the molecular weight cut-off centrifugal filters. 
 
 
Figure 25. (a) Profinity IMAC nickel affinity chromatography purification of EGF27 in Shuffle T7 
Express lysY cells expressed in LB media. (b) Bio-Rad ENrich SEC 70 gel filtration 
chromatography purification of the IMAC purified EGF27 sample. 
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2.3.2 Reversed-phase HPLC 
The EGF27-6XHis samples purified with gel filtration were analyzed by reversed phase 
high performance liquid chromatography (RP-HPLC) using a Purity Semi-Prep HPLC C18 
column. A linear gradient from 0 to 75% solvent B (100% acetonitrile containing 0.1% TFA) in 
solvent A (water with 0.1% TFA) for 45 minutes at a 2 mL/min flow rate was applied to elute the 
folding isoforms of the protein. The protein sample was treated with 15 mM dithiothreitol (DTT) or 
15 mM calcium chloride. All samples were adjusted to 0.1% TFA before analysis. DTT reduces 
disulfide bonds formed between the cysteine residues and unfolds the protein. EGF27-6XHis has 
a predicted calcium binding site, so adding calcium may alter the retention time of EGF27-6XHis 
to aid in identifying the correct peak. RP-HPLC elution of EGF27-6XHis was recorded at 214 nm. 
Figure 26 (a) shows that in the absence of DTT, the sample elutes at 26.1 min and in presence 
of DTT, the peak migrates and elutes at 28.6 min. The peak at 26.1 minute most likely has all 
three disulfide bonds correctly formed, and the addition of DTT reduces them, so the peak shifts 
to 28.6 min. Therefore, the sharp peak eluting at 26.1 min is most likely the properly folded 
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Figure 26. (a) Reversed-phase HPLC elution profile in presence and absence of DTT or CaCl2. A 
peak at 26.1 min disappears and appears at 28.6 min when DTT was added to EGF27-6XHis 
sample. (b) SDS-PAGE gel image of the RP-HPLC samples eluted at 23 min (lane 2) and 26 min 
(lane 3). 
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EGF27-6XHis, and the peak eluting next to it around 28.6 min is most likely its reduced form. 
These results suggest that the shift in retention time with DTT identifies disulfide-bonded EGF27-
6XHis. The peaks did not shift noticeably in the absence or presence of calcium chloride, so this 
shows that the addition of calcium did not affect the retention time of EGF27-6XHis significantly. 
Peaks eluting at 23.5 min and 29.6 min remain unchanged in absence or presence of DTT or 
CaCl2. Fractions of eluents from individual peaks were collected separately based on the 214 nm 
absorbance profile and freeze dried on a lyophilizer. The samples eluting at 23 min and 26 min 
were analyzed by SDS-PAGE, Figure 26 (b), and matrix-assisted laser desorption/ionization time 
of flight mass spectrometry (MALDI-TOF/TOF MS) to confirm the molecular weight of EGF27-
6XHis (discussed in section 2.3.3). 
2.3.3 Mass Spectrometry 
The samples obtained from RP-HPLC were spotted on the MALDI target plate (Bruker 
Daltonics MTP 384 massive target T) and analyzed by Bruker UltrafleXtreme MALDI-TOF/TOF 
MS in the LSU Mass Spectrometry Facility. The molecular weight of EGF27-6XHis is 7109.76 
daltons as determined from the protein sequence using Swiss Institute of Bioinformatics – 
ExPASY Bioinformatics Resource Portal. Figure 27 shows the MALDI-MS spectra with mass to 
charge (m/z) ratio 7109, confirming the molecular weight of the purified protein to be correct. 
Hence, from these observations and analyses, the protein purified is EGF27-6XHis. MALDI-MS 
analysis of the RP-HPLC elutions at 23 min and 26 min also confirms both to be EGF27-6XHis 
peaks. The peak eluting at 23 min does not shift after the addition of DTT though, unlike the peak 
eluting at 26 min. It is not clear what isoform of EGF27-6XHis elutes at 23 min. In the next step, 
we isotopically labeled EGF27-6XHis using 15N-NH4Cl in the expression media and analyzed the 
“foldedness” of the protein with 1H-15N HSQC NMR. 
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2.3.4 1H-15N HSQC NMR 
The EGF27-6XHis was expressed in minimal media with isotopic labeling using 15N-NH4Cl 
as previously described (in section 2.2.3). The protein was purified using nickel affinity 
chromatography followed by gel filtration chromatography as previously discussed. The peak 
eluting later on the gel filtration chromatogram was deduced to be the properly folded EGF27 from 
previous analyses and were pooled. The molecular weight was confirmed by running a sample 
on an SDS-PAGE gel. The 15N-EGF27 protein sample was concentrated using a 3 kDa MWCO 
centrifugal filter. The NMR sample was prepared in a 250 μL total volume containing 10% D2O, 
90% H2O, and 0.5 μL of 1% (w/v) DSS in D2O for chemical shift referencing. The concentration 
of the NMR sample was determined to be 0.5 mM. A D2O matched 5 mm Shigemi tube was used 
to hold the sample. A gradient sensitivity enhanced HSQC (gNhsqc) experiment was run with 16 
scans and 256 number of increments at 27°C temperature. 
Figure 27. MALDI mass spectrometry spectra showing mass to charge (m/z) ratio to be 7109 of 
the EGF27-6XHis sample. 
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Each 1H atom attached to the 15N atom on the backbone or the side chain of the protein 
corresponds to each peak in the 1H-15N HSQC spectrum. Figure 28 shows the HSQC spectrum 
of 0.5 mM 15N-EGF27-6XHis in 10% D2O. The peaks in the spectra are not well dispersed 
indicating that the protein is cross-linked or is not correctly folded.  
2.4 Discussion and Conclusions 
The goal of this project was to express and purify milligram quantities of properly folded 
monomeric EGF repeats and determine the three dimensional structure of the protein using NMR 
spectroscopy. In order to obtain a good spectrum for protein structural studies using NMR 
spectroscopy, a protein concentration of at least 0.5 mM is required. Proteins with molecular 
weights ranging from 7 to 9 kDa require about a milligram of properly folded protein in 250 μL 
total sample volume to give a concentration of 0.5 mM.  
Figure 28. (a) SDS-PAGE gel image of the 15N-EGF27 purification with βME (lane 2) and without 
βME (lane 3) using Enrich SEC 70. (b) 1H-15N HSQC spectrum of 15N labeled EGF27 showing 
mostly undispersed peaks. 
(a) (b) 
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We started the expressions in LB media using three tandem EGF repeats in a single 
construct for EGF26-27-28 and EGF25-26-27. After purification, the final yield of the monomeric 
EGF26-27-28 protein was found to be very low (in microgram quantities) and not enough to 
prepare samples for NMR. The tri-repeat sequence was aggregating possibly due to inter-
molecular disulfide bonds. EGF25-26-27, in particular, is susceptible to intermolecular disulfide 
bond formation due to the presence of an extra cysteine residue in the EGF25 sequence. In order 
to reduce the chances of inter-repeat cross-linking and increase the chance of proper disulfide-
mediated folding, we cloned two EGF domains together instead of three domains.  
EGF25-26-C21G was cloned by mutating the extra cysteine residue in EGF25 to a glycine 
residue. This protein was expressed in BL21-Gold(DE3) cells and upon purification, we observed 
that the protein was in multimeric form. Thus, this sample was not suitable for NMR analysis. In 
order to overcome the problem of protein cross-linking during expression and purification steps, 
we used an enhanced green fluorescent protein as a fusion with a TEV cleavage site in between 
them. 
The use of the green fluorescent protein as a fusion partner is one technique for promoting 
proper protein folding. It also acts as a reporter of proper folding.41 EGF25-26-C21G, pelB-EGF27, 
and EGF27 without pelB were cloned separately with the green fluorescent protein as a fusion. 
The amount of target protein produced by this method after the TEV cleavage reaction was 
relatively low and was not enough to produce the isotopically labeled protein in milligram 
quantities required for our NMR studies. 
During the green fluorescent protein fusion trial expressions, we noticed that the EGF27 
construct without the pelB leader sequence was expressing significantly higher compared to the 
one with the pelB sequence. In the next step, we cloned a single EGF repeat (EGF27) without 
the pelB leader sequence and without the green fluorescent fusion partner. This construct was 
expressed in both BL21-Gold(DE3) and Shuffle T7 Express cells. After purification, we found that 
the protein expressed in Shuffle cells yielded significantly higher amount of monomeric protein. 
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2.5 Future work 
We have found that EGF27-6XHis expressed in Shuffle cells produce correctly folded, 
disulfide bonded protein with an increased yield. In our initial protein purification attempts for 
EGF27-6XHis expressed in Shuffle cells, we found that the protein forms oligomers while 
concentrating during sample preparation for NMR. Thus, in the next steps we need to find a way 
to keep the protein stable in its natively folded state without aggregation after purification. Once 
we successfully produce milligram quantities of properly folded protein, we will be able to run 
NMR experiments required for elucidating the three dimensional structure of the protein. 
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A) SEQUENCES: 
 
1) Mouse Notch1 (mN1) EGF1-36 nucleotide sequence: 
The mN1 EGF1-36 nucleotide sequence is shown below. The first three codons of each EGF 
repeats from EGF1 to EGF36 are shown in bold alphabets. 
ggcttgagatgctcccagccaagtgggacctgcctgaatggaggtaggtgcgaagtggccagcggcactg
aagcctgtgtctgcagcggagcctttgtgggccaacgatgccaggactccaatccttgcctcagcacacc
gtgtaagaatgctggaacgtgccacgttgtggaccatggtggcactgtggattatgcctgcagctgtccc
ctgggtttctctgggcccctctgcctgacacctctggacaacgcctgcctggccaacccctgccgcaatg
ggggcacctgtgacctgctcactctcacagagtacaagtgccgctgcccaccagggtggtcaggaaaatc
atgtcagcaggctgacccctgtgcctccaacccctgtgccaatggtggccagtgcctgccctttgagtct
tcatacatctgtcgctgcccgcctggcttccatggccccacctgcaggcaagatgttaatgagtgcagcc
agaaccctgggctgtgccgccatggaggcacctgccacaatgagatcggctcctatcgctgtgcctgccg
tgccacccatactggtccccactgtgaactgccctatgtgccctgcagcccctcaccctgccagaatgga
ggcacctgccgtcctacaggggacaccacccacgagtgtgcctgcttgccaggttttgctggacagaact
gtgaagaaaatgtggatgactgtccaggaaacaactgcaagaatgggggtgcctgtgtggacggcgtgaa
tacctacaattgccgctgcccaccggagtggacgggtcagtactgtacagaggatgtggacgaatgtcag
ctcatgcccaatgcctgccagaatggcggaacctgccacaacacacacggcggctacaactgtgtgtgtg
tcaatgggtggactggcgaggactgcagtgagaacattgatgactgtgccagtgccgcctgtttccaggg
tgccacttgccacgaccgtgtggcttccttctactgcgaatgtccgcatgggcgcacaggtctgctgtgc
cacctcaacgatgcgtgcatcagcaacccctgcaacgagggctccaactgtgacaccaaccctgtcaacg
gcaaagccatctgcacctgcccctcggggtacacagggccagcctgcagccaggacgtggatgagtgtgc
tctgggtgccaacccttgtgagcacgcaggcaaatgcctcaacacactgggttcttttgagtgccagtgt
ctacagggctacacgggaccccgctgtgagattgatgttaatgagtgcatctccaacccatgtcagaatg
atgccacttgcctggaccagattggggagttccaatgcatatgtatgccaggttatgaaggtgtatactg
tgaaatcaacacggatgagtgcgccagcagcccctgtctgcacaatggccactgcatggacaagatcaat
gagttccaatgtcagtgccccaaaggcttcaacgggcacctgtgccagtatgatgtggatgagtgtgcca
gcacaccatgcaagaacggtgccaagtgcctggatgggcccaacacctatacctgcgtgtgtacagaagg
ttacacagggacccactgcgaagtggacattgacgagtgtgaccctgacccctgccactatggttcctgt
aaggatggtgtggccacctttacctgcctgtgccagccaggctacacaggccatcactgtgagaccaaca
tcaatgagtgccacagccaaccgtgccgccatgggggcacctgccaggaccgtgacaactcctacctctg
cttatgcctcaagggaaccacagggcccaactgtgagatcaacctggatgactgcgccagcaacccctgt
gactctggcacctgtctggacaagattgatggctacgaatgtgcctgtgaaccaggctacacaggaagca
tgtgtaacgtcaacattgacgaatgtgcgggcagcccctgccacaacgggggcacttgtgaggatggcat
cgcgggcttcacttgccgctgccccgagggctaccatgaccccacgtgcctgtccgaggtcaacgagtgc
aacagtaacccctgcatccacggagcttgccgggatggcctcaatgggtacaagtgtgactgtgcccctg
ggtggagtggaacaaactgtgacatcaacaacaacgagtgtgagtccaacccttgtgtcaacggtggcac
ctgcaaggacatgaccagtggctacgtatgcacctgccgagaaggcttcagtggccctaattgccagacc
aacatcaacgaatgtgcctccaacccctgcctgaaccaggggacctgcattgatgatgtcgctggataca
agtgcaactgtcctctgccatatacaggagccacgtgtgaggtggtgttggccccatgtgctaccagccc
ctgcaaaaacagcggggtatgcaaggagtctgaagactatgagagtttttcctgtgtctgtcccacaggc
tggcaaggtcaaacctgcgaggttgacatcaatgagtgtgtgaaaagcccatgtcgccatggggcctcct
gccagaacaccaatggcagctaccgctgcctctgccaggccggctatacaggtcgcaactgtgagagtga
catcgatgactgccgccccaacccgtgtcacaatgggggttcctgcaccgatggcatcaacacagccttc
tgcgactgcctgcccggcttccagggtgccttctgtgaggaggacatcaatgaatgtgccagcaatccct
gccaaaatggtgccaattgcactgactgtgtggacagctacacatgtacctgccccgtgggcttcaatgg
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catccactgcgagaacaacacacctgactgtactgagagctcctgcttcaatggtggtacctgtgtggat
ggtatcaactccttcacctgtctgtgtccacctggcttcacgggcagctactgtcagtatgatgtcaatg
agtgtgattcacggccctgtctgcacggtggtacctgccaagacagctatggtacttataagtgtacctg
cccacagggctacactggtctcaactgccagaaccttgtgcgctggtgcgactcggctccctgcaagaat
ggtggcaggtgctggcagaccaacacgcagtaccactgtgagtgccgcagcggctggactggcgtcaact
gcgacgtgctcagtgtgtcctgtgaggtggctgcacagaagcgaggcattgacgtcactctcctgtgcca
gcatggagggctctgtgtggatgagggagataaacattactgccactgccaggcaggctacacgggcagc
tactgtgaggacgaggtggacgagtgctcacctaacccctgccagaatggagctacctgcactgactatc
tcggcggcttttcctgcaagtgtgtggctggctaccatgggtctaactgctcagaggagatcaacgagtg
cctgtcccagccctgccagaatgggggtacctgcattgatctgaccaactcctacaagtgttcctgcccc
cgggggacacagggtgtacactgtgagatcaatgttgatgactgccatcccccccttgaccctgcctccc
gaagccccaagtgcttcaacaatggcacctgtgtggaccaggtgggtggctatacctgcacctgcccacc
aggcttcgtcggggagcggtgtgagggtgatgtcaatgaatgtctctccaacccctgtgacccacgtggc
acccagaactgtgtgcagcgtgttaatgacttccactgcgagtgccgggctggccacactggacgccgct
gtgagtcagtcatcaatggctgcaggggcaaaccttgcaagaatgggggtgtctgtgccgtggcctccaa
caccgcccgtggattcatctgtaggtgccctgcgggcttcgagggtgccacatgtgagaatgatgcccgc
acttgtggcagcttacgctgcctcaacggtggtacatgcatctcgggcccacgtagtcccacctgcctat
gcctgggatccttcaccggccctgagtgccagttcccagccagcagcccctgtgtgggtagcaacccctg
ctacaatcagggcacctgtgagcccacatccgagaaccctttctaccgctgtctatgccctgccaaattc
aacgggctactgtgccacatcctgg 
 
2) mN1 EGF1-36 amino acid sequence: 
mN1 EGF1-36 sequence has 1408 amino acid residues. The first amino acid residue of each EGF 
repeat is shown in bold alphabet. Cysteine (C) at position 943 is highlighted in grey. 
GVAALGSGSTGDAAQPARRARRTYEASGLRCSQPSGTCLNGGRCEVASGTEACVCSGAFVGQRCQDSNPC
LSTPCKNAGTCHVVDHGGTVDYACSCPLGFSGPLCLTPLDNACLANPCRNGGTCDLLTLTEYKCRCPPGW
SGKSCQQADPCASNPCANGGQCLPFESSYICRCPPGFHGPTCRQDVNECSQNPGLCRHGGTCHNEIGSYR
CACRATHTGPHCELPYVPCSPSPCQNGGTCRPTGDTTHECACLPGFAGQNCEENVDDCPGNNCKNGGACV
DGVNTYNCRCPPEWTGQYCTEDVDECQLMPNACQNGGTCHNTHGGYNCVCVNGWTGEDCSENIDDCASAA
CFQGATCHDRVASFYCECPHGRTGLLCHLNDACISNPCNEGSNCDTNPVNGKAICTCPSGYTGPACSQDV
DECALGANPCEHAGKCLNTLGSFECQCLQGYTGPRCEIDVNECISNPCQNDATCLDQIGEFQCICMPGYE
GVYCEINTDECASSPCLHNGHCMDKINEFQCQCPKGFNGHLCQYDVDECASTPCKNGAKCLDGPNTYTCV
CTEGYTGTHCEVDIDECDPDPCHYGSCKDGVATFTCLCQPGYTGHHCETNINECHSQPCRHGGTCQDRDN
SYLCLCLKGTTGPNCEINLDDCASNPCDSGTCLDKIDGYECACEPGYTGSMCNVNIDECAGSPCHNGGTC
EDGIAGFTCRCPEGYHDPTCLSEVNECNSNPCIHGACRDGLNGYKCDCAPGWSGTNCDINNNECESNPCV
NGGTCKDMTSGYVCTCREGFSGPNCQTNINECASNPCLNQGTCIDDVAGYKCNCPLPYTGATCEVVLAPC
ATSPCKNSGVCKESEDYESFSCVCPTGWQGQTCEVDINECVKSPCRHGASCQNTNGSYRCLCQAGYTGRN
CESDIDDCRPNPCHNGGSCTDGINTAFCDCLPGFQGAFCEEDINECASNPCQNGANCTDCVDSYTCTCPV
GFNGIHCENNTPDCTESSCFNGGTCVDGINSFTCLCPPGFTGSYCQYDVNECDSRPCLHGGTCQDSYGTY
KCTCPQGYTGLNCQNLVRWCDSAPCKNGGRCWQTNTQYHCECRSGWTGVNCDVLSVSCEVAAQKRGIDVT
LLCQHGGLCVDEGDKHYCHCQAGYTGSYCEDEVDECSPNPCQNGATCTDYLGGFSCKCVAGYHGSNCSEE
INECLSQPCQNGGTCIDLTNSYKCSCPRGTQGVHCEINVDDCHPPLDPASRSPKCFNNGTCVDQVGGYTC
TCPPGFVGERCEGDVNECLSNPCDPRGTQNCVQRVNDFHCECRAGHTGRRCESVINGCRGKPCKNGGVCA
VASNTARGFICRCPAGFEGATCENDARTCGSLRCLNGGTCISGPRSPTCLCLGSFTGPECQFPASSPCVG
SNPCYNQGTCEPTSENPFYRCLCPAKFNGLLCHILDTRGGPEQKLISEEDLNSAVDHHHHL 
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3) EGF26-27-28 nucleotide sequence: 
aacacacctgactgtactgagagctcctgcttcaatggtggtacctgtgtggatggtatcaactccttca
cctgtctgtgtccacctggcttcacgggcagctactgtcagtatgatgtcaatgagtgtgattcacggcc
ctgtctgcacggtggtacctgccaagacagctatggtacttataagtgtacctgcccacagggctacact
ggtctcaactgccagaaccttgtgcgctggtgcgactcggctccctgcaagaatggtggcaggtgctggc
agaccaacacgcagtaccactgtgagtgccgcagcggctggactggcgtcaactgcgacgtg 
 
4) EGF26-27-28-6XHis translated amino acid sequence from pET-28b vector: 
EGF26-27-28 sequence is underlined below. EGF26-28 has amino acid residues from E961 to 
S1078 based on 1408 residues of EGF1-36.  
MGENNTPDCTESSCFNGGTCVDGINSFTCLCPPGFTGSYCQYDVNECDSRPCLHGGTCQDSYGTYKCTCP
QGYTGLNCQNLVRWCDSAPCKNGGRCWQTNTQYHCECRSGWTGVNCDVLSLEHHHHHH 
Theoretical pI/MW: 5.63 / 14118.48 
 
5) EGF25-26-27 nucleotide sequence: 
gacatcaatgaatgtgccagcaatccctgccaaaatggtgccaattgcactgactgtgtggacagctaca
catgtacctgccccgtgggcttcaatggcatccactgcgagaacaacacacctgactgtactgagagctc
ctgcttcaatggtggtacctgtgtggatggtatcaactccttcacctgtctgtgtccacctggcttcacg
ggcagctactgtcagtatgatgtcaatgagtgtgattcacggccctgtctgcacggtggtacctgccaag
acagctatggtacttataagtgtacctgcccacagggctacactggtctcaactgccagaac 
 
6) EGF25-26-27-6XHis translated amino acid sequence from pET-28b vector: 
EGF25-26-27 sequence is underlined below. EGF25-27 has amino acid residues from E923 to 
V1040 based on 1408 residues of EGF1-36. 
MGEEDINECASNPCQNGANCTDCVDSYTCTCPVGFNGIHCENNTPDCTESSCFNGGTCVDGINSFTCLCP
PGFTGSYCQYDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVLEHHHHHH 
Theoretical pI/MW: 4.53 / 13824.04 
 
7) EGF25-26-C21G nucleotide sequence: 
gacatcaatgaatgtgccagcaatccctgccaaaatggtgccaattgcactgactgtgtggacagctaca
catgtacctgccccgtgggcttcaatggcatccactgcgagaacaacacacctgactgtactgagagctc
ctgcttcaatggtggtacctgtgtggatggtatcaactccttcacctgtctgtgtccacctggcttcacg
ggcagctactgtcagtat 
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8) EGF25-26-C21G-6XHis translated amino acid sequence from pET-28a vector: 
EGF25-26-C21G sequence is underlined below. EGF25-26-C21G has amino acid residues from 
E924 to Q999 based on 1408 residues of EGF1-36. Cysteine (C) at position 943 based on EGF1-
36 or at position 21 based on EGF25-26 sequence is mutated to Glycine (G), which is highlighted 
in grey. 
MEDINECASNPCQNGANCTDGVDSYTCTCPVGFNGIHCENNTPDCTESSCFNGGTCVDGINSFTCLCPPG
FTGSYCQKHHHHHH 
Theoretical pI/MW: 4.94 / 8987.75 
 
9) EGF27 nucleotide sequence: 
gatgtcaatgagtgtgattcacggccctgtctgcacggtggtacctgccaagacagctatggtacttata
agtgtacctgcccacagggctacactggtctcaactgccagaac 
 
10) EGF27-6XHis translated amino acid sequence from pET-28a vector: 
EGF27 sequence is underlined below. EGF27 has amino acid residues from D1001 to W1042 
based on 1408 residues of EGF1-36. 
MDIGINSDPNSDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVRWAAALEHHHHHH 
Theoretical pI/MW: 5.87 / 7109.76 
 
11) EGF25-26-C21G-TEV-EGFP-6XHis translated amino acid sequence from pLIC-
EGFP vector: 
EGF25-26-C21G-TEV-EGFP sequence is underlined below. 
MGTSNPFKLMEDINECASNPCQNGANCTDGVDSYTCTCPVGFNGIHCENNTPDCTESSCFNGGTCVDGIN
SFTCLCPPGFTGSYCQKLGLINLENLYFQSVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYG
KLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRA
EVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD
HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH 
Theoretical pI/MW: 5.50 / 38536.20 
Protein sequences after TEV protease: 
EGF25-26: 
TEV protease recognition sequence is underlined below. 
MGTSNPFKLMEDINECASNPCQNGANCTDGVDSYTCTCPVGFNGIHCENNTPDCTESSCFNGGTCVDGIN
SFTCLCPPGFTGSYCQKLGLINLENLYFQ  
Theoretical pI/MW: 3.92 / 10559.71 
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EGFP-His: 
SVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQ
CFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSK
DPNEKRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH  
Theoretical pI/MW: 6.07 / 27994.50 
 
12) pLIC-EGF27-TEV-EGFP-6XHis translated amino acid sequence from pLIC-EGFP 
vector: 
EGF27 sequence is underlined below. 
MGTSNPFKLMDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVRWRKLGLINLENLYFQSVSK
GEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSR
YPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEY
NYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNE
KRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH 
Theoretical pI/Mw: 6.21 / 35474.03 
Protein sequences after TEV protease: 
EGF27: 
TEV protease recognition sequence is underlined below. 
MGTSNPFKLMDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVRWRKLGLINLENLYFQ 
Theoretical pI/Mw: 7.57 / 7497.55 
EGFP-His: 
SVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQ
CFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSK
DPNEKRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH 
Theoretical pI/Mw: 6.07 / 27994.50 
 
13) pelB-EGF27-TEV-EGFP-6XHis translated amino acid sequence from pLIC-EGFP 
vector: 
EGF27 sequence is underlined below. 
MGTSNPFKLMKYLLPTAAAGLLLLAAQPAMAMDIGINSDPNSDVNECDSRPCLHGGTCQDSYGTYKCTCP
QGYTGLNCQNLVRWRKLGLINLENLYFQSVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGK
LTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAE
VKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH
YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH 
Theoretical pI/Mw: 6.12 / 38697.82 
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Periplasmic proteolytic digestion of pelB: 
EGF27 sequence is underlined below. 
MDIGINSDPNSDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVRWRKLGLINLENLYFQSVS
KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFS
RYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLE
YNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPN
EKRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH 
Theoretical pI/Mw: 5.95 / 35510.90 
Protein sequences after TEV protease: 
EGF27: 
TEV protease recognition sequence is underlined below. 
MDIGINSDPNSDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVRWRKLGLINLENLYFQ 
Theoretical pI/Mw: 4.94 / 7534.42 
pelB-EGF27: 
TEV protease recognition sequence is underlined below. 
MGTSNPFKLMKYLLPTAAAGLLLLAAQPAMAMDIGINSDPNSDVNECDSRPCLHGGTCQDSYGTYKCTCP
QGYTGLNCQNLVRWRKLGLINLENLYFQ 
Theoretical pI/Mw: 6.51 / 10721.34 
EGFP-His: 
SVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQ
CFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSK
DPNEKRDHMVLLEFVTAAGITLGMDELYKHHHHHHHH 
Theoretical pI/Mw: 6.07 / 27994.50 
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